Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine
- on behalf of the Portuguese HIV-1 Resistance Study Group
Research output: Contribution to journal › Article › peer-review
15
Citations
(Scopus)